journal article·2011-07Open access

Surface-enhanced Raman scattering studies on bombesin, its selected fragments and related peptides adsorbed at the silver colloidal surface

Edyta Podstawka-Proniewicz, Yukihiro Ozaki, Younkyoo Kim, Yizhuang Xu, Leonard M. Proniewicz

Applied Surface Science· Volume 257· Issue 19

Abstract

Abstract SERS studies presented in this work on BN 8–14 , [ d -Phe 6 ,β-Ala 11 ,Phe 13 ,Nle 14 ]BN 6–14 , [ d -Tyr 6 , β-Ala 11 ,Phe 13 ,Nle 14 ]BN 6–14 , BN and its modified analogues, as well as NMB , NMC , and PG-L show that these molecules at pH 8.3 bind to a colloidal silver surface mainly through Trp 8 and Met 14 residues. Trp 8 adsorbs at the surface almost perpendicularly. Met 14 appears on the surface mainly as a P C -G conformer. His 12 , as is evident from the spectra, practically does not take part in the adsorption process. Substitution of l -leucine at the 13 position of amino acid sequence with l -phenylalanine does not change substantially the pattern of the adsorption mechanism; however, substitution of phenylalanine at the 12 position (instead of l -histidine) causes changes in the SERS spectra that show that Phe 12 takes parallel orientation to the surface upon adsorption of [ d -Phe 12 ]BN , while in the case of [Tyr 4 , d -Phe 12 ]BN this residue is perpendicular to the surface and influences the orientation of the bound Trp 8 . On the other hand, substitution of Asn with Tyr in the 6 position in nonapeptide fragment causes changes in the adsorption mechanism. In this case, the discussed fragment binds to the silver colloidal surface by Tyr 6 , Trp 8 , and Met 14 . The SERS spectrum of NMC is very similar to that of BN ; although it differs by the binding orientation of the amide bond towards the surface. Appearance of Phe 13 in NMB and PG-L causes that this residue competes successfully with Trp 8 forcing it to take tilted orientation. As seen from the enhancement of the characteristic Phe vibrations this moiety in NMB and PG-L adsorbs on the silver surface in a tilted fashion. This arrangements cause that the 8–14 peptide chain in all these studied compounds takes almost a parallel orientation to the surface while the 1–5 fragment of the peptide chain is removed from the silver surface vicinity.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanocluster Synthesis and Applications · Gold and Silver Nanoparticles Synthesis and Applications · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (67)

Show source-provided references
1. Anastasi · Experientia · 1971 · 27 · 16610.1007/BF02145873 ↗
2. Ohki-Hamazaki · Int. J. Dev. Biol. · 2005 · 49 · 29310.1387/ijdb.041954ho ↗
3. Preston · Br. J. Cancer · 1995 · 71 · 108710.1038/bjc.1995.210 ↗
4. Marion-Audibert · Gastroenterol. Clin. Biol. · 2000 · 24 · 644
5. Rozengurt · Trends Endocrinol. Metab. · 2002 · 13 · 12810.1016/S1043-2760(01)00544-6 ↗
6. Sunday · 1997
7. Aprikian · Int. J. Cancer · 1997 · 72 · 49810.1002/(SICI)1097-0215(19970729)72:3<498::AID-IJC19>3.0.CO;2-8 ↗
8. Erspamer · Peptides · 1984 · 5 · 76510.1016/0196-9781(84)90019-6 ↗
9. Smith · 2002 · 1666
10. Lin · J. Pharmacol. Exp. Ther. · 1995 · 294 · 55
11. Jensen · 1994 · 1337
12. Moody · Life Sci. · 1985 · 37 · 10510.1016/0024-3205(85)90413-8 ↗
13. Westendorf · J. Biol. Chem. · 1983 · 258 · 752710.1016/S0021-9258(18)32209-9 ↗
14. Mantey · J. Biol. Chem. · 2001 · 276 · 921910.1074/jbc.M008737200 ↗
15. Kull · J. Biol. Chem. · 1992 · 267 · 2113210.1016/S0021-9258(19)36807-3 ↗
16. Coy · J. Biol. Chem. · 1988 · 263 · 505610.1016/S0021-9258(18)60678-7 ↗
17. Knight · 1990 · 185
18. Nishino · Am. J. Physiol. Gastrointest. Liver Physiol. · 1998 · 274 · 52510.1152/ajpgi.1998.274.3.G525 ↗
19. Bevis · Ann. Rev. Biochem. · 1990 · 59 · 39510.1146/annurev.bi.59.070190.002143 ↗
20. Aguayo · Clin. Invest. · 1989 · 84 · 110510.1172/JCI114273 ↗
21. King · Proc. Natl. Acad. Sci. U.S.A. · 1995 · 92 · 435710.1073/pnas.92.10.4357 ↗
22. Ryan · J. Pharmacol. Exp. Ther. · 1999 · 290 · 120210.1016/S0022-3565(24)35024-4 ↗
23. Grinder · Am. J. Phys. Gastrointest. Liver Physiol. · 2004 · 287 · G110910.1152/ajpgi.00080.2004 ↗
24. Krane · J. Biol. Chem. · 1988 · 263 · 1331710.1016/S0021-9258(18)37707-X ↗
25. Cullen · Am. J. Respir. Crit. Care Med. · 2002 · 165 · 109310.1164/ajrccm.165.8.2108044 ↗
26. Subramaniam · Am. J. Respir. Crit. Care Med. · 2003 · 168 · 60110.1164/rccm.200212-1434OC ↗
27. Endo · J. Endocrinol. · 1991 · 131 · 31310.1677/joe.0.1310313 ↗
28. Carney · Cancer Res. · 1987 · 47 · 821
29. Jensen · 2006
30. Montet · Bioconjug. Chem. · 2006 · 17 · 90510.1021/bc060035+ ↗
31. Frucht · Clin. Cancer Res. · 1999 · 5 · 2532
32. Scopinaro · Cancer Biother. Radiopharm. · 2002 · 17 · 32710.1089/10849780260179297 ↗
33. Moody · J. Biol. Chem. · 2004 · 279 · 2358010.1074/jbc.M401938200 ↗
34. Katsuno · Biochemistry · 1999 · 38 · 730710.1021/bi990204w ↗
35. Kroog · Med. Res. Rev. · 1995 · 15 · 38910.1002/med.2610150502 ↗
36. Ruff · Clin. Immunol. Immunopathol. · 1985 · 37 · 38710.1016/0090-1229(85)90108-4 ↗
37. Lebacq-Verheyden · 1990 · vol. 95 · 71
38. Sunday · Anat. Rec. · 1993 · 238 · 2510.1002/ar.1092360107 ↗
39. Podstawka · Biopolymers · 2008 · 89 · 50610.1002/bip.20909 ↗
40. Podstawka · Biopolymers · 2008 · 89 · 98010.1002/bip.21047 ↗
41. Podstawka · Appl. Spectrosc. · 2004 · 58 · 114710.1366/0003702042336073 ↗
42. Podstawka-Proniewicz · J. Phys. Chem. B · 2010 · 114 · 511710.1021/jp910575f ↗
43. Podstawka · Biopolymers · 2006 · 83 · 19310.1002/bip.20545 ↗
44. Podstawka · Langmuir · 2008 · 24 · 1080710.1021/la8012415 ↗
45. Podstawka · J. Phys. Chem. B · 2009 · 113 · 497810.1021/jp8110716 ↗
46. Herne · J. Am. Chem. Soc. · 1991 · 113 · 84610.1021/ja00003a018 ↗
47. Podstawka · Appl. Spectrosc. · 2004 · 58 · 57010.1366/000370204774103408 ↗
48. Podstawka · J. Phys. Chem. B · 2009 · 113 · 1097410.1021/jp903847c ↗
49. Podstawka · J. Phys. Chem. B · 2010 · 114 · 101010.1021/jp909268c ↗
50. Moskovits · Langmuir · 1988 · 4 · 6710.1021/la00079a012 ↗
51. Nakanishi · J. Biosci. Bioeng. · 2001 · 91 · 23310.1016/S1389-1723(01)80127-4 ↗
52. Carter · Langmuir · 1992 · 8 · 121810.1021/la00040a033 ↗
53. Podstawka · Biopolymers · 2008 · 89 · 80710.1002/bip.21017 ↗
54. Podstawka · Biopolymers · 2008 · 89 · 94110.1002/bip.21040 ↗
55. Nogami · Bull. Chem. Soc. Jpn. · 1975 · 48 · 241710.1246/bcsj.48.2417 ↗
56. Ozaki · Chem. Lett. · 1975 · 71310.1246/cl.1975.713 ↗
57. Stewart · Spectrochim. Acta A · 1999 · 55 · 161510.1016/S1386-1425(98)00293-5 ↗
58. Gaigalas · J. Colloid Interface Sci. · 1998 · 29910.1006/jcis.1998.5509 ↗
59. Razmute · Chemija · 2006 · 17 · 25
60. Zhao · Langmuir · 2002 · 18 · 43310.1021/la010542+ ↗
61. Cao · J. Phys. Chem. B · 2003 · 107 · 76910.1021/jp026747o ↗
62. Martusevicius · Vib. Spectrosc. · 1996 · 10 · 27110.1016/0924-2031(95)00025-9 ↗
63. Siamwiza · Biochemistry · 1975 · 14 · 487010.1021/bi00693a014 ↗
64. Yu · Arch. Biochem. Biophys. · 1973 · 156 · 7110.1016/0003-9861(73)90342-1 ↗
65. Rava · J. Phys. Chem. · 1985 · 89 · 185610.1021/j100256a007 ↗
66. Suh · J. Am. Chem. Soc. · 1986 · 108 · 471110.1021/ja00276a005 ↗
67. Curley · Langmuir · 1988 · 4 · 102110.1021/la00082a037 ↗